BACH1 as a potential target for immunotherapy in glioblastomas
Feng Yuan(Anhui Medical University), Chiyuan Ma(Tongji University), Xiangming Cai(Southeast University), Yingshuai Wang(Ludwig-Maximilians-Universität München), Lei Yuan(Guangzhou University of Chinese Medicine), Chao Tang(North Sichuan Medical University), Zixiang Cong(Shandong University), Junhao Zhu(Nanjing Medical University)
Cited by 21
Related Papers
Genomic monitoring of SARS-CoV-2 uncovers an Nsp1 deletion variant that modulates type I interferon response
|Cell Host & Microbe|2021|140
Risk Factors for Rebleeding of Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis
|PLoS ONE|2014|129
Real-time detection of 20 amino acids and discrimination of pathologically relevant peptides with functionalized nanopore
|Nature Methods|2024|122
Molecular subgroups and B7-H4 expression levels predict responses to dendritic cell vaccines in glioblastoma: an exploratory randomized phase II clinical trial
|Cancer Immunology Immunotherapy|2018|111